Comparing 0 vendors in Spatial Genomics and Transcriptomics across 0 criteria.
The Spatial Genomics & Transcriptomics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Spatial Genomics & Transcriptomics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 40 companies of which the Top xx Spatial Genomics & Transcriptomics Companies were categorized and recognized as the quadrant leaders.
Contenders
Emerging Companies
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
2.1 DRIVERS
2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery &
development
2.1.2 Introduction of novel products
2.1.3 Increasing R&D investments and public-private funding
2.2 RESTRAINTS
2.2.1 High capital investments
2.3 OPPORTUNITIES
2.3.1 Increasing use of spatial omics for biomarker identification
2.4 CHALLENGES
2.4.1 Dearth of skilled professionals
3.1 INTRODUCTION
3.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS
3.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS)
3.4 MARKET SHARE ANALYSIS (2021)
3.5 COMPANY EVALUATION QUADRANT
3.5.1 STARS
3.5.2 EMERGING LEADERS
3.5.3 PERVASIVE PLAYERS
3.5.4 PARTICIPANTS
4.1 KEY PLAYERS
4.1.1 NANOSTRING TECHNOLOGIES
TABLE 248 NANOSTRING TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 31 NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT (2021)
4.1.2 10X GENOMICS
TABLE 249 10X GENOMICS: BUSINESS OVERVIEW
FIGURE 32 10X GENOMICS: COMPANY SNAPSHOT (2021)
4.1.3 ILLUMINA
TABLE 250 ILLUMINA: BUSINESS OVERVIEW
FIGURE 33 ILLUMINA: COMPANY SNAPSHOT (2021)
4.1.4 BIO-RAD LABORATORIES
TABLE 251 BIO-RAD: BUSINESS OVERVIEW
FIGURE 34 BIO-RAD: COMPANY SNAPSHOT (2021)
4.1.5 BIO-TECHNE
TABLE 252 BIO-TECHNE: BUSINESS OVERVIEW
FIGURE 35 BIO-TECHNE: COMPANY SNAPSHOT (2021)
4.1.6 STANDARD BIOTOOLS
TABLE 253 STANDARD BIOTOOLS: BUSINESS OVERVIEW
FIGURE 36 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
4.1.7 GENOMIC VISION SA
TABLE 254 GENOMIC VISION: BUSINESS OVERVIEW
FIGURE 37 GENOMIC VISION: COMPANY SNAPSHOT (2021)
4.1.8 AKOYA BIOSCIENCES
TABLE 255 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 38 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
4.1.9 PERKINELMER
TABLE 258 PERKINELMER: BUSINESS OVERVIEW
FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2021)
4.1.10 SEVEN BRIDGES GENOMICS
TABLE 259 SEVEN BRIDGES GENOMICS: BUSINESS OVERVIEW
4.1.11 S2 GENOMICS
TABLE 260 S2 GENOMICS: BUSINESS OVERVIEW
4.1.12 CANTATA BIO
TABLE 261 CANTATA BIO: BUSINESS OVERVIEW
4.1.13 VIZGEN CORP
TABLE 262 VIZGEN: BUSINESS OVERVIEW
4.2 OTHER PLAYERS
4.2.1 BIOSPYDER TECHNOLOGIES
4.2.2 OPTICAL BIOSYSTEMS
4.2.3 MILTENYL BIOTEC
4.2.4 RARECYTE
4.2.5 ULTIVUE
4.2.6 LUNAPHORE TECHNOLOGIES
4.2.9 SINGULAR GENOMICS
4.2.10 VERACYTE
Company Profiles
Strategy, financials, growth, and SWOT
Market Insights
Visual quadrant of competitors and leaders
Benchmarking
Compare by product, region, and end-user
Lead Gen Add-on
Use the quadrant to attract clients
Spatial genomics and transcriptomics are advanced techniques that combine spatial information with genomic or transcriptomic data. These methods allow scientists to analyze the spatial arrangement of cells and their gene expression patterns within tissues, providing insights into the complex organization and function of biological systems.
These techniques involve capturing spatial information about cells within a tissue sample using imaging or sequencing technologies. Spatially resolved data is then combined with genomic or transcriptomic analysis to map gene expression patterns to specific locations within the tissue.
In oncology, these techniques are pivotal in exploring tumor heterogeneity, identifying predictive biomarkers of response, and developing more effective immunotherapies by offering insights into the tumor microenvironment.
Academic research institutions, pharmaceutical companies, and biotechnology firms are key players adopting spatial genomics and transcriptomics to accelerate discoveries in disease biology and drug development.
Computational tools are essential for processing, visualizing, and analyzing the vast datasets generated. They enable the integration of spatial and transcriptomic data and help derive meaningful biological insights.
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Email : [email protected]
Quick Links
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Company
Headquarters
Year Founded
Holding Type